GNPTAB activators comprise a group of chemicals that facilitate the enhancement of the activity or expression of the GNPTAB protein, which is a critical component in the lysosomal enzyme targeting pathway. GNPTAB, the alpha and beta subunit of the GlcNAc-1-phosphotransferase enzyme, is essential for the catalysis of the initial step in the synthesis of the mannose 6-phosphate recognition marker on lysosomal hydrolases. This tagging is crucial for the proper sorting and transport of these enzymes to the lysosomes, the cellular organelles responsible for breaking down various macromolecules.
Activators of GNPTAB can function through direct mechanisms, such as binding to the regulatory regions of the protein and promoting its catalytic efficiency. These chemicals might induce conformational changes that enhance the enzyme's affinity for its substrates or its catalytic turnover rate. The precise binding sites and conformational alterations depend on the structural biology of the GNPTAB protein and the chemical nature of the activator. Such a direct interaction would be highly specific and would require a detailed understanding of the protein's active site architecture and allosteric regulation. Indirect activators may not interact with the GNPTAB protein itself but could increase its activity by upregulating its expression or stabilizing the protein to ensure a longer cellular half-life. These could include small molecules that influence the transcriptional activity of the GNPTAB gene or that modulate the stability of its mRNA transcripts, thereby increasing the overall levels of the GNPTAB protein. Additionally, activators might target cellular signaling pathways that converge on the regulation of GNPTAB, thereby adjusting the protein's activity post-translationally through phosphorylation, acetylation, or ubiquitination. Such modifications can enhance the protein's stability or its interaction with co-factors and substrates, leading to increased functional output.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
A potent activator of adenylyl cyclase, Forskolin can increase intracellular cAMP levels. The elevated cAMP can enhance the activity of GNPTAB, which is responsible for the phosphorylation of mannose residues on N-linked oligosaccharides in lysosomal enzyme proteins. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases (PDEs). By inhibiting PDEs, IBMX increases intracellular cAMP levels, which can subsequently enhance GNPTAB activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Epinephrine stimulates adrenergic receptors, leading to the activation of adenylyl cyclase and an increase in cAMP levels. The resultant increase in cAMP can enhance GNPTAB activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram is a selective PDE4 inhibitor that increases intracellular cAMP levels, thereby enhancing GNPTAB activity. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $107.00 $316.00 | 3 | |
Cilostazol is a PDE3 inhibitor that increases cAMP levels, leading to enhanced GNPTAB activity. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine, by activating D1-like receptors, can increase adenylyl cyclase activity, thereby elevating cAMP levels and enhancing GNPTAB activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol is a nonselective beta-adrenergic agonist that increases cAMP levels, thereby enhancing GNPTAB activity. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $90.00 $371.00 | 2 | |
Terbutaline, a beta2-adrenergic receptor agonist, increases cAMP levels, thus enhancing GNPTAB activity. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $33.00 $47.00 $294.00 $561.00 $1020.00 $2550.00 $4590.00 | 1 | |
Adenosine, by binding to A2A receptors, can activate adenylyl cyclase, increasing cAMP levels and enhancing GNPTAB activity. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
PGE2 is a prostaglandin that increases intracellular cAMP levels via the EP2 and EP4 receptors, enhancing GNPTAB activity. |